Investing.com - Guardant Health (NASDAQ: GH) reported first quarter EPS of $-0.46, $0.41 better than the analyst estimate of $-0.87. Revenue for the quarter came in at $168.5M versus the consensus estimate of $150.04M.
Guidance
Guardant Health sees FY 2024 revenue of $675.00M-$685.00M versus the analyst consensus of $663.70M.
Guardant Health's stock price closed at $19.44. It is down -14.02% in the last 3 months and down -29.49% in the last 12 months.
Guardant Health saw 1 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Guardant Health's stock price’s past reactions to earnings here.
According to InvestingPro, Guardant Health's Financial Health score is "fair performance".
Check out Guardant Health's recent earnings performance, and Guardant Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar